🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with numerous of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could lead to users administering products of unknown origin.

Several experts stated the demand for retatrutide could be connected to the increasing price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Response and Material Removal

According to TikTok, the platform has taken down problematic material and prohibited related hashtags and query recommendations. The organization said it was dedicated to maintaining the platform secure and investing in enhancing compliance measures.

Digital Trading Operations

Investigations also discovered communities with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, positive reviews and step-by-step guides for mixing or administering at residence.

Within moments of joining one community, a seller shared contact information, where most purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Item Information and Costs

Inside these groups, messages show black plastic packages with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Even if the research behind this drug is sound, these digital products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has already seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to potentially serious medical dangers”.